Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-10T11:56:23.523Z Has data issue: false hasContentIssue false
  • English
  • Français

Plasma nortriptyline and clinical response–a study using changing plasma levels

Published online by Cambridge University Press:  09 July 2009

Graham D. Burrows ,
Kay P. Maguire ,
Bruce A. Scoggins ,
James Stevenson  and
Brian Davies
Graham D. Burrows
Affiliation:
From the Department of Psychiatry, University of Melbourne, Royal Melbourne Hospital and Howard Florey Institute of Experimental Physiology and Medicine, University of Melbourne, Australia
Kay P. Maguire
Affiliation:
From the Department of Psychiatry, University of Melbourne, Royal Melbourne Hospital and Howard Florey Institute of Experimental Physiology and Medicine, University of Melbourne, Australia
Bruce A. Scoggins
Affiliation:
From the Department of Psychiatry, University of Melbourne, Royal Melbourne Hospital and Howard Florey Institute of Experimental Physiology and Medicine, University of Melbourne, Australia
James Stevenson
Affiliation:
From the Department of Psychiatry, University of Melbourne, Royal Melbourne Hospital and Howard Florey Institute of Experimental Physiology and Medicine, University of Melbourne, Australia
Brian Davies*
Affiliation:
From the Department of Psychiatry, University of Melbourne, Royal Melbourne Hospital and Howard Florey Institute of Experimental Physiology and Medicine, University of Melbourne, Australia
*
1Address for correspondence: Professor Brian Davies, Clinical Sciences Block, Royal Melbourne Hospital, Melbourne, Victoria 3050, Australia.
Get access Rights & Permissions [Opens in a new window]

Synopsis

In a 5-week study of 22 depressed patients treated with nortriptyline, significant changes in plasma levels, both elevated and reduced, were deliberately produced in the third and fourth weeks of each patient's treatment. Correlation of plasma nortriptyline levels and changes in the severity of depression, as measured by the Hamilton Depression Scale, showed no significant relationships. The implications of the study are discussed.

Type
Research Article
Information
Psychological Medicine , Volume 7 , Issue 1 , February 1977 , pp. 87 - 91
Copyright
Copyright © Cambridge University Press 1977

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

Äsberg, M., Cronholm, B., Sjöqvist, F. & Tuck, D. (1971). Relationship between plasma level and therapeutic effect of nortriptyline. British Medical Journal iii, 331–334.CrossRefGoogle Scholar
Braithwaite, R. A., Goulding, R., Theano, G., Bailey, J. & Coppen, A. (1972). Plasma concentration of amitriptyline and clinical response. Lancet i, 1297–1300.CrossRefGoogle Scholar
Burrows, G. D. (1973). Clinical and pharmacological studies in depressive illness. M.D. Thesis, University of Melbourne.Google Scholar
Burrows, G. D., Davies, B. & Scoggins, B. A. (1972). Plasma concentration of nortriptyline and clinical response in depressive illness. Lancet ii, 619–623.CrossRefGoogle Scholar
Burrows, G. D., Scoggins, B. A., Turecek, L. R. & Davies, B. (1974 a). Plasma nortriptyline and clinical response. Clinical Pharmacology and Therapeutics 16, 639–644.CrossRefGoogle ScholarPubMed
Burrows, G. D., Vohra, J., Hunt, D., Sloman, J. G., Scoggins, B. A. & Davies, B. (1974 b). Cardiological aspects of tricyclic antidepressants. Journal de Pharmacologie 5, Suppl. 2, 13.Google Scholar
Coppen, A. & Montgomery, S. (1975). Effective dosage of tricyclic antidepressants. British Medical Journal i, 91.CrossRefGoogle Scholar
Forrest, P. & Davies, B. (1977). (In the press).Google Scholar
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology. Neurosurgery and Psychiatry 23, 56–62.CrossRefGoogle ScholarPubMed
Hammer, H. M. & Brodie, B. (1967). Application of isotope derivative technique to the assay of secondary amines: estimation of desimipramine by acetylation with 3H-acetic anhydride. Journal of Pharmacology and Experimental Therapeutics 157, 503–506.Google Scholar
Kragh Sørenson, P., Äsberg, M. & Eggert-Hansen, C. (1973). Plasma nortriptyline levels in endogenous depression. Lancet i, 113–115.CrossRefGoogle Scholar
Kragh Sørenson, P., Eggert-Hansen, C., Larsen, N. E., Naestoft, J. & Hvidberg, E. F. (1974). Long-term treatment of endogenous depression with nortriptyline with control of plasma levels. Psychological Medicine 4, 174–180.CrossRefGoogle Scholar
Lyle, W. H. (1975). Effective dosage of tricyclic antidepressants. British Medical Journal i, 91–92.CrossRefGoogle Scholar
Lyle, W. H., Brooks, P. W., Early, D. F., Laggett, W. P., Silverman, G., Braithwaite, R. A., Cuthill, J. M., Goulding, R., Pearson, L. B., Snaith, R. P. & Strang, G. E. (1974). Plasma concentration of nortriptyline as a guide to treatment. Postgraduate Medical Journal 50, 282–287.CrossRefGoogle Scholar
Maguire, K. P., Burrows, G. D., Coghlan, J. P. & Scoggins, B. A. (1976). A rapid radioisotopic procedure for the determination of plasma nortriptyline. Clinical Chemistry 22 (6), 761–764.CrossRefGoogle Scholar
Verghese, A., Burrows, G. D., Stevenson, J. & Davies, B. (1976). Observer variation and depressive phenomenology. Psychological Medicine 6, 587–590.CrossRefGoogle ScholarPubMed
Vohra, J., Burrows, G. D., Sloman, J. G. & Hunt, D. (1975). Assessment of cardiovascular side effects of therapeutic doses of tricyclic antidepressant drugs. Australia and New Zealand Journal of Medicine 5, 7–11.CrossRefGoogle Scholar